PREVIOUS
✖
TNPSC BITS
February 1 , 2022
903 days
858
0
- The Drugs Controller General of India (DCGI) granted its approval to Bharat Biotech for the trials of its intranasal Covid booster dose in India.
Leave a Reply
Your Comment is awaiting moderation.